Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments..pdf (502.88 kB)
Download file

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.

Download (502.88 kB)
journal contribution
posted on 04.08.2015, 09:41 by R. Coppo, S. Troyanov, S. Bellur, D. Cattran, H. T. Cook, John Feehally, I. S. Roberts, L. Morando, R. Camilla, V. Tesar, S. Lunberg, L. Gesualdo, F. Emma, C. Rollino, A. Amore, M. Praga, S. Feriozzi, G. Segoloni, A. Pani, G. Cancarini, M. Durlik, E. Moggia, G. Mazzucco, C. Giannakakis, E. Honsova, B. B. Sundelin, A. M. Di Palma, F. Ferrario, E. Gutierrez, A. M. Asunis, Jonathan Barratt, R. Tardanico, A. Perkowska-Ptasinska, VALIGA study of the ERA-EDTA Immunonephrology Working Group
The Oxford Classification of IgA Nephropathy (IgAN) identified mesangial hypercellularity (M), endocapillary proliferation (E), segmental glomerulosclerosis (S), and tubular atrophy/interstitial fibrosis (T) as independent predictors of outcome. Whether it applies to individuals excluded from the original study and how therapy influences the predictive value of pathology remain uncertain. The VALIGA study examined 1147 patients from 13 European countries that encompassed the whole spectrum of IgAN. Over a median follow-up of 4.7 years, 86% received renin-angiotensin system blockade and 42% glucocorticoid/immunosuppressive drugs. M, S, and T lesions independently predicted the loss of estimated glomerular filtration rate (eGFR) and a lower renal survival. Their value was also assessed in patients not represented in the Oxford cohort. In individuals with eGFR less than 30 ml/min per 1.73 m(2), the M and T lesions independently predicted a poor survival. In those with proteinuria under 0.5 g/day, both M and E lesions were associated with a rise in proteinuria to 1 or 2 g/day or more. The addition of M, S, and T lesions to clinical variables significantly enhanced the ability to predict progression only in those who did not receive immunosuppression (net reclassification index 11.5%). The VALIGA study provides a validation of the Oxford classification in a large European cohort of IgAN patients across the whole spectrum of the disease. The independent predictive value of pathology MEST score is reduced by glucocorticoid/immunosuppressive therapy.

History

Citation

Kidney International, 2014, 86 (4), pp. 828-836

Author affiliation

/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Infection, Immunity and Inflammation

Version

VoR (Version of Record)

Published in

Kidney International

Publisher

Nature Publishing Group for International Society of Nephrology

eissn

1523-1755

Acceptance date

02/01/2014

Copyright date

2014

Available date

04/08/2015

Publisher version

http://www.nature.com/ki/journal/v86/n4/full/ki201463a.html

Language

en